Dyne Therapeutics, Inc. (DYN)
19.42
-0.27
(-1.37%)
USD |
NASDAQ |
Dec 11, 16:00
19.42
0.00 (0.00%)
After-Hours: 07:37
Dyne Therapeutics Free Cash Flow: -397.01M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Avidity Biosciences, Inc. | -592.26M |
| CEL-SCI Corp. | -17.36M |
| AIM ImmunoTech, Inc. | -13.33M |
| IGC Pharma, Inc. | -6.262M |
| NovaBay Pharmaceuticals, Inc. | -7.012M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -90.78M |
| Cash from Investing (Quarterly) | -37.96M |
| Cash from Financing (Quarterly) | 217.33M |
| Free Cash Flow Per Share (Quarterly) | -0.7754 |
| Free Cash Flow to Equity (Quarterly) | -109.35M |
| Free Cash Flow to Firm (Quarterly) | -107.06M |
| Free Cash Flow Yield | -17.48% |